OtherClinical Investigations (Human)
Open Access
A Prospective Study on 18F-DCFPyL PSMA PET/CT Imaging in Biochemical Recurrence of Prostate Cancer
Etienne Rousseau, Don Wilson, Frédéric Lacroix-Poisson, Andra Krauze, Kim Chi, Martin Gleave, Michael McKenzie, Scott Tyldesley, S. Larry Goldenberg and François Bénard
Journal of Nuclear Medicine April 2019, jnumed.119.226381; DOI: https://doi.org/10.2967/jnumed.119.226381
Etienne Rousseau
1 BC Cancer, Canada;
Don Wilson
1 BC Cancer, Canada;
Frédéric Lacroix-Poisson
1 BC Cancer, Canada;
Andra Krauze
1 BC Cancer, Canada;
Kim Chi
1 BC Cancer, Canada;
Martin Gleave
2 University of British Columbia, Canada
Michael McKenzie
1 BC Cancer, Canada;
Scott Tyldesley
1 BC Cancer, Canada;
S. Larry Goldenberg
2 University of British Columbia, Canada
François Bénard
1 BC Cancer, Canada;

Article Figures & Data
Additional Files
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
A Prospective Study on 18F-DCFPyL PSMA PET/CT Imaging in Biochemical Recurrence of Prostate Cancer
Etienne Rousseau, Don Wilson, Frédéric Lacroix-Poisson, Andra Krauze, Kim Chi, Martin Gleave, Michael McKenzie, Scott Tyldesley, S. Larry Goldenberg, François Bénard
Journal of Nuclear Medicine Apr 2019, jnumed.119.226381; DOI: 10.2967/jnumed.119.226381
A Prospective Study on 18F-DCFPyL PSMA PET/CT Imaging in Biochemical Recurrence of Prostate Cancer
Etienne Rousseau, Don Wilson, Frédéric Lacroix-Poisson, Andra Krauze, Kim Chi, Martin Gleave, Michael McKenzie, Scott Tyldesley, S. Larry Goldenberg, François Bénard
Journal of Nuclear Medicine Apr 2019, jnumed.119.226381; DOI: 10.2967/jnumed.119.226381
Jump to section
Related Articles
Cited By...
- Changes in Management After 18F-DCFPyL PSMA PET in Patients Undergoing Postprostatectomy Radiotherapy, with Early Biochemical Response Outcomes
- Predictors of 18F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy
- 18F-DCFPyL PET Acquisition, Interpretation, and Reporting: Suggestions After Food and Drug Administration Approval
- Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on 18F-Fluciclovine PET/CT Guidance
- The Effects of Monosodium Glutamate on PSMA Radiotracer Uptake in Men with Recurrent Prostate Cancer: A Prospective, Randomized, Double-Blind, Placebo-Controlled Intraindividual Imaging Study
- 18F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local Therapy
- Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment
- Prospective Evaluation of 18F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management